KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Buildings (2016 - 2017)

Historic Buildings for Regeneron Pharmaceuticals (REGN) over the last 6 years, with Q4 2017 value amounting to $1.4 billion.

  • Regeneron Pharmaceuticals' Buildings rose 1277.35% to $1.4 billion in Q4 2017 from the same period last year, while for Dec 2017 it was $1.4 billion, marking a year-over-year increase of 1277.35%. This contributed to the annual value of $1.4 billion for FY2017, which is 1277.35% up from last year.
  • Per Regeneron Pharmaceuticals' latest filing, its Buildings stood at $1.4 billion for Q4 2017, which was up 1277.35% from $1.3 billion recorded in Q4 2016.
  • Over the past 5 years, Regeneron Pharmaceuticals' Buildings peaked at $1.4 billion during Q4 2017, and registered a low of $343.4 million during Q4 2013.
  • Over the past 5 years, Regeneron Pharmaceuticals' median Buildings value was $760.5 million (recorded in 2015), while the average stood at $844.5 million.
  • Its Buildings has fluctuated over the past 5 years, first soared by 9061.48% in 2015, then surged by 1277.35% in 2017.
  • Regeneron Pharmaceuticals' Buildings (Quarter) stood at $343.4 million in 2013, then rose by 16.2% to $399.0 million in 2014, then skyrocketed by 90.61% to $760.5 million in 2015, then skyrocketed by 68.08% to $1.3 billion in 2016, then rose by 12.77% to $1.4 billion in 2017.
  • Its Buildings stands at $1.4 billion for Q4 2017, versus $1.3 billion for Q4 2016 and $760.5 million for Q4 2015.